系统性红斑狼疮患者伴或不伴心血管危险因素的皮肤微血管功能障碍
SLE患者在再灌注期峰值幅度显著低于对照(161.0% vs 197.2%,P=0.002),且在24例无心血管疾病的SLE患者中结果不变(169.2% vs 195.6%,P=0.002)。结论提示SLE患者即使无明确心血管疾病或危险因素,也存在微血管反应性减弱,可能是血管损伤的早期标志。
要点
- SLE患者再灌注期皮肤微血管峰值幅度低于对照(P=0.002)。
- 无心血管疾病的SLE患者仍存在微血管反应性减弱(P=0.002)。
- 皮肤微血管功能障碍可能独立于心血管负荷,是早期血管损伤标志。
核心结论
- SLE患者即使无明确心血管疾病或危险因素,再灌注期皮肤微血管反应性仍较对照减弱,提示微血管功能障碍独立于心血管负荷存在。
主要发现
- 再灌注期SLE患者峰值幅度低于对照(161.0% vs 197.2%,P=0.002)。
- 24例无心血管疾病的SLE患者再灌注期峰值幅度仍低于对照(169.2% vs 195.6%,P=0.002)。
临床怎么用
- LASCA检测的皮肤微血管再灌注反应减弱可作为SLE患者早期血管损伤的提示指标,即使无传统心血管危险因素也需关注微血管功能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Patients with SLE have increased cardiovascular mortality. Alterations in both macro- and micro-circulation have been associated with cardiovascular disease. We sought to assess skin microvascular function by using laser speckle contrast analysis (LASCA) in patients with SLE, with and without cardiovascular disease and risk factors. METHODS: Continuous blood flow was recorded using a LASCA device during baseline, a 5-min arterial occlusion and a 5-min reperfusion period. RESULTS: Thirty-five patients with SLE (85.7% women) with a median disease duration 12.0 (6.5-17.5) years and a mean age of 46.3 (8.6) years and 31 controls matched for age, sex and BMI were enrolled. During reperfusion, SLE patients exhibited a smaller peak magnitude compared with controls (161.0 (47.1) vs 197.2 (41.4)%, respectively, P =0.002). Results remained unchanged among 24 SLE patients without cardiovascular disease compared with the control group (169.2 (48.1) vs 195.6 (34.0)%, respectively, P =0.002). CONCLUSION: Our study shows, for the first time, that patients with SLE, even without overt cardiovascular disease or risk factors, exhibit a blunted microvascular reactivity during reperfusion compared with controls. These results show that skin microvascular dysfunction is present in SLE independently of the CV burden that these patients bear and may represent an early sign of vascular damage.
引用
- Koletsos N, Gkaliagkousi E, Lazaridis A, et al. Skin microvascular dysfunction in systemic lupus erythematosus patients with and without cardiovascular risk factors. Rheumatology (Oxford). 2021. PMID: 33383584. doi:10.1093/rheumatology/keaa722
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。